We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Angel Biotech | LSE:ABH | London | Ordinary Share | GB00B0HZJ337 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.05 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jun 2019 to Jun 2024
TIDMABH
RNS Number : 6048X
Angel Biotechnology Holdings Plc
11 February 2013
11 February 2013
Angel Biotechnology Holdings plc
("the Company")
Appointment of administrators
Further to its announcement of 8 February 2013, the Company announces that Blair Carnegie Nimmo and Gary Steven Fraser of KPMG LLP have been appointed as joint administrators to the Company.
For further information:
Angel Biotechnology Holdings plc +44 (0) 131 445 6077
Grant Thornton, Corporate Finance
Colin Aaronson / Melanie Frean +44 (0) 20 7383 5100
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGGUQCPUPWGPG
1 Year Angel Biotechnology Chart |
1 Month Angel Biotechnology Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
